Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006

Andrew P Steenhoff1, Sarah M Wood, Richard M Rutstein

  • 1Division of Special Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. steenhoff@email.chop.edu

Insights

Invasive pneumococcal disease (IPD) incidence decreased in HIV-infected children after highly active antiretroviral therapy (HAART) introduction. Further monitoring is needed to assess the impact of the heptavalent pneumococcal conjugate vaccine (PCV7) on IPD in this population.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The heptavalent pneumococcal conjugate vaccine (PCV7) has reduced invasive pneumococcal disease (IPD) in the general pediatric population.
  • Limited data exist on IPD trends in children with human immunodeficiency virus (HIV).

Purpose of the Study:

  • To investigate the incidence and characteristics of IPD in perinatally HIV-infected children.
  • To evaluate the impact of highly active antiretroviral therapy (HAART) and PCV7 on IPD rates in this cohort.

Main Methods:

  • A retrospective study analyzing diagnostic codes and laboratory records for IPD cases in children (<18 years) at an urban HIV clinic from 1989 to 2006.
  • IPD incidence rates were calculated, and serotype distribution and antibiotic resistance patterns were analyzed.

Main Results:

  • A total of 256 children were followed for 1756 person-years, with 21 IPD episodes observed.
  • IPD incidence significantly decreased by 84% after HAART introduction (1862/100,000 PY to 292/100,000 PY).
  • Following PCV7 introduction, a non-significant increase in IPD incidence was noted (292/100,000 PY to 860/100,000 PY).

Conclusions:

  • HAART significantly reduced IPD incidence in perinatally HIV-infected children.
  • The effect of PCV7 on IPD in this vulnerable population requires ongoing surveillance.
  • Antibiotic resistance to penicillin and trimethoprim-sulfamethoxazole remains a concern.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...